Tofacitinib (CP-690550) Citrate - Moligand™,≥99% , Janus Kinase (JAK) inhibitor, CAS No.540737-29-9, Janus Kinase (JAK) inhibitor

CAS: 540737-29-9 Cat. No.: E129454 Summenformel: C16H20N6O.C6H8O7 Molekulargewicht: 504.49 EG-Nummer: 638-826-4
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%
Synonyms
D09783 | Xeljanz | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate | CP-690550 Citrate (Tofacitinib Citrate) | UNII-O1FF4DIV0D | 3-((3R,4R)-4-Methyl-3-(methyl(7H
Storage
Store at 2-8°C,Protected from light
Shipped In
Wet ice
★
Größe
Deutschland (EU)
USA*
Preis
Menge
10mg
E129454-10mg
—
3 Auf Lager
8,59€
50mg
E129454-50mg
—
3 Auf Lager
9,46€
250mg
E129454-250mg
—
Auf Lager ≥10
19,87€
1g
E129454-1g
—
8 Auf Lager
48,51€
5g
E129454-5g
—
2 Auf Lager
173,46€
Enter a quantity for the sizes you want to add.
🧪
Warum diese Qualität

Moligand™, ≥99% Moligand™ für empfindliche chromatographische und analytische Workflows, die minimale Basislinieninterferenzen erfordern.

🌡

Lagerung & Versand

Store at 2-8°C,Protected from light Versand Wet ice. Genaue Spezifikationen finden Sie im chargenspezifischen COA.

📋

Qualitätsdokumente

SDS, COA, Datenblatt und Spezifikationsblatt stehen zum Download bereit. Chargenspezifische COA über Chargennummernsuche abrufbar.

📚

Literaturbeleg

In 2 peer-reviewten Publikationen zu Chromatographie, organischer Synthese und Kreuzkupplungsreaktionen zitiert.

Übersicht

Tofacitinib (CP-690550) Citrate is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.
A selective JAK3 inhibitor

Spezifikationen

Synonyme
D09783 | Xeljanz | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate | CP-690550 Citrate (Tofacitinib Citrate) | UNII-O1FF4DIV0D | 3-((3R,4R)-4-Methyl-3-(methyl(7H
Spezifikationen & Reinheit
Moligand™, ≥99%
Biochemische und physiologische Mechanismen
Tofacitinib is a potent inhibitor of JAK3 (Janus kinase 3) with some JAK1 inhibitory activity as well. JAK3 blocks downstream STAT signaling resulting in potent inhibition of inflammatory cytokines with resultant immunosuppressive and anti-inflammatory ac
Rechtliche Informationen
Sold for only research purposes
Storage
Store at 2-8°C,Protected from light
Verschickt in
Wet ice
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Janus Kinase (JAK) inhibitor
Hinweis
Toxic, refer to SDS for further information . Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Reinheit
≥99%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488196565
Kanonisches Lächeln
CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
IUPAC Name
2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
InChIKey
SYIKUFDOYJFGBQ-YLAFAASESA-N
INCHI
1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
Isomere SMILES
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
WGK Deutschland
3
Molekulargewicht
504.49
Reaxy-Rn
14655003
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=14655003&ln=

Dokumentation

📋 Sicherheitsdatenblatt (SDS)

Umfassendes Dokument zu Gefahren, Handhabung, Lagerung und Einhaltung regulatorischer Vorschriften.

<<<<<<< HEAD SDS herunterladen → ======= SDS herunterladen → >>>>>>> release248-p3

✅ Analysezertifikat (COA)

Chargenspezifische Qualitätsdaten. Geben Sie Ihre Chargennummer ein, um das genaue COA abzurufen.

COA nachschlagen →

📊 Datenblatt

Kurzübersicht über Produktspezifikationen und Anwendungen.

Datenblatt ansehen →

🔬 Spezifikationsblatt

Vollständige Qualitätsmerkmale und Akzeptanzkriterien für diese Qualität.

Spezifikationsblatt ansehen →

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlassePiperidines
SubclassN-acylpiperidines
Intermediate Tree Nodes Not available
Direct ParentN-acylpiperidines
Alternative Parents Tricarboxylic acids and derivatives  Pyrrolo[2,3-d]pyrimidines  Dialkylarylamines  Aminopyrimidines and derivatives  Aminopiperidines  Imidolactams  Tertiary carboxylic acid amides  Pyrroles  Heteroaromatic compounds  Nitriles  Azacyclic compounds  Organopnictogen compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkNot available
Substituents N-acyl-piperidine - Pyrrolopyrimidine - Tricarboxylic acid or derivatives - Pyrrolo[2,3-d]pyrimidine - Dialkylarylamine - 3-aminopiperidine - Aminopyrimidine - Pyrimidine - Imidolactam - Heteroaromatic compound - Pyrrole - Tertiary carboxylic acid amide - Carboxamide group - Nitrile - Carbonitrile - Carboxylic acid derivative - Azacycle - Organic nitrogen compound - Organooxygen compound - Organonitrogen compound - Organic oxide - Carbonyl group - Organopnictogen compound - Organic oxygen compound - Hydrocarbon derivative - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as n-acylpiperidines. These are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of a piperidine.
External Descriptors citrate salt
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DCLK3 Tchem Serine/threonine-protein kinase DCLK3 (296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRIM24 Tchem Transcription intermediary factor 1-alpha (2087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRPF1 Tchem Peregrin (2217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

14 results found

Lot NumberCertificate TypeDatumArtikel
G1520063G1520063Certificate of AnalysisAug 13, 2026 E129454
D1901054D1901054Certificate of AnalysisMay 21, 2026 E129454
K2503405K2503405Certificate of AnalysisOct 22, 2025 E129454
K2503434K2503434Certificate of AnalysisOct 22, 2025 E129454
K2513693K2513693Certificate of AnalysisOct 22, 2025 E129454
B2215632B2215632Certificate of AnalysisSep 09, 2025 E129454
B2215644B2215644Certificate of AnalysisSep 09, 2025 E129454
B2215653B2215653Certificate of AnalysisSep 09, 2025 E129454
L2124045L2124045Certificate of AnalysisJul 14, 2025 E129454
G2308098G2308098Certificate of AnalysisApr 18, 2025 E129454
G2308093G2308093Certificate of AnalysisApr 18, 2025 E129454
B2215659B2215659Certificate of AnalysisDec 12, 2023 E129454
B2212163B2212163Certificate of AnalysisJan 10, 2022 E129454
B2212165B2212165Certificate of AnalysisJan 10, 2022 E129454
Chemische und physikalische Eigenschaften
LöslichkeitSoluble in DMSO (100 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), DMF (~5 mg/ml), water (<1 mg/ml at 25 °C), and 0.5% methylcellulose (30 mg/ml at 25 °C).
EmpfindlichkeitMoisture sensitive, Light sensitive
Molekulargewicht504.500 g/mol
XLogP3
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count12
Rotatable Bond Count8
Exact Mass504.197 Da
Monoisotopic Mass504.197 Da
Topological Polar Surface Area221.000 Ų
Heavy Atom Count36
Formal Charge0
Complexity716.000
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count2
FAQs und Artikel
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.